This is an expanded use protocol for patients diagnosed with aMycobacterium avium complex (MAC). Sponsored by Novartis, the purpose of this program is to make clofazimine available to appropriate patients following clinical presentation.
Global Health Institute
This is an expanded use protocol for patients diagnosed with aMycobacterium avium complex (MAC). Sponsored by Novartis, the purpose of this program is to make clofazimine available to appropriate patients following clinical presentation.